March 11, 2013 - ZOLL Wins Patent Infringement Case Against ELan Med GMBH
MEDIA CONTACT: |
Diane Egan |
ZOLL WINS PATENT INFRINGEMENT CASE AGAINST ELan Med GMBH
German Company Ordered to Halt Manufacture and Sale of Infringing Products for Therapeutic Hypothermia
March 11, 2013—CHELMSFORD, MASS.—ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that the District Court of Munich, Germany, ruled in favor of ZOLL in granting an injunction against ELan Med GmbH of Cologne, Germany, for infringing on a ZOLL patent through the distribution and sale of certain ELan products for use with ZOLL’s Intravascular Temperature Management (IVTM™) systems.
Under the terms of the judgment, ELan has been ordered to stop the manufacture and sale of infringing products for use with ZOLL’s patented temperature management systems (the Thermogard XP® and CoolGard 300® intravascular temperature management systems). The court also ruled that ZOLL is entitled to recover damages resulting from sales of the infringing products that were incurred since January 18, 2012, and ordered ELan to pay 90% of the cost of the court proceedings.
“We place a high value on our intellectual property and will pursue all available legal remedies against companies or individuals who attempt to capitalize on our innovative technologies by patent infringement,” said James Palazzolo, President of ZOLL. “We are gratified that the court has acknowledged ZOLL’s temperature management system patent.”
ZOLL’s IVTM system provides cooling and warming through a balloon catheter inserted into the patient’s venous system. A startup kit is used to connect the Thermogard XP or CoolGard 300 temperature management console with a catheter to either warm or cool the saline as it flows through the catheter. This approach provides more accurate control of core body temperature than surface methods can, since it directly cools or warms the patient’s blood as it flows through the body.
Since the saline flows only within the catheter, no fluid is infused into the patient. ZOLL offers a variety of triple-lumen catheters with placement options to handle specific patient challenges. The ZOLL IVTM system is efficient, precise, and easy to use, and frees up clinical staff to attend to other patient needs.
About ZOLL Medical Corporation
ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care. For more information, visit www.zoll.com.
About Asahi Kasei
The Asahi Kasei Group is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the chemicals and fibers, homes and construction materials, electronics, and health care business sectors. Its health care operations include devices and systems for critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals, diagnostic reagents, and nutritional products. With more than 25,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries. For more information, visit www.asahi-kasei.co.jp/asahi/en/.
Copyright © 2013 ZOLL Medical Corporation. All rights reserved. CoolGard, IVTM, Thermogard, and ZOLL are trademarks or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All trademarks are the property of their respective owners.